Lupin (company)

Lupin Limited
TypePublic
BSE: 500257
NSE: LUPIN
IndustryPharmaceuticals
Founded1968 (1968)
FounderDesh Bandhu Gupta
Headquarters,
India
Key peopleVinita D. Gupta (CEO)
Nilesh Gupta (MD)
Products
RevenueIncrease ₹22,192 crore (US$2.3 billion) (2025)
Increase ₹5,277 crore (US$550 million) (2025)
Increase ₹3,281 crore (US$340 million) (2025)
Total assetsIncrease ₹29,204 crore (US$3.0 billion) (2025)
Total equityIncrease ₹17,294 crore (US$1.8 billion) (2025)
Number of employees
20,000+ (2023)
Websitewww.lupin.com
Footnotes
Financials as of 31 March 2025.

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.The company operates in multiple international markets including the United States, Japan, Europe, and Australia..